SERA
SERA PROGNOSTICS, INC.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$2.07
+6.99%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 57.17x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.37x
- Price / sales
- 1163.76x
- Price / cash flow
- -2.94x
Enterprise value
- Enterprise value
- $38.0M
- EV / sales
- 543.13x
- EV / EBITDA
- -1.18x
- EV / EBIT
- -1.02x
- Market cap
- $81.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026